Prostaglandin D2
Overview[edit]
Prostaglandin D2 (PGD2) is a prostaglandin, a type of bioactive lipid that plays a significant role in various physiological and pathological processes. It is one of the major prostaglandins produced by the mast cells and is involved in the regulation of allergic reactions, inflammation, and sleep.
Biosynthesis[edit]
Prostaglandin D2 is synthesized from arachidonic acid through the cyclooxygenase (COX) pathway. The enzyme prostaglandin D synthase catalyzes the conversion of prostaglandin H2 (PGH2) to PGD2. There are two main types of prostaglandin D synthase: lipocalin-type prostaglandin D synthase and hematopoietic prostaglandin D synthase.
Biological Functions[edit]
PGD2 is involved in a variety of biological functions:
- Allergic Reactions: PGD2 is released by mast cells during allergic responses and contributes to the symptoms of asthma and allergic rhinitis.
- Inflammation: It acts as a mediator in the inflammatory process, influencing the recruitment and activation of immune cells.
- Sleep Regulation: PGD2 is implicated in the regulation of sleep-wake cycles, promoting non-rapid eye movement sleep (NREM sleep).
- Hair Growth: PGD2 has been shown to inhibit hair growth, and elevated levels are associated with androgenetic alopecia.
Receptors[edit]
Prostaglandin D2 exerts its effects through binding to specific G protein-coupled receptors (GPCRs):
- DP1 Receptor: This receptor is involved in the vasodilation and inhibition of platelet aggregation.
- DP2 Receptor (also known as CRTH2): This receptor is associated with the chemotaxis of eosinophils, basophils, and T-helper 2 cells.
Clinical Significance[edit]
Due to its role in allergic and inflammatory responses, PGD2 is a target for therapeutic intervention in conditions such as asthma and allergic diseases. Inhibitors of PGD2 synthesis or receptor antagonists are being explored as potential treatments.
